Analysis of Structure−Activity Relationships for MT2 Selective Antagonists by Melatonin MT1 and MT2 Receptor Models

Journal of Medicinal Chemistry
2005.0

Abstract

Three-dimensional homology models of human MT(1) and MT(2) melatonin receptors were built with the aim to investigate the structure-activity relationships (SARs) of MT(2) selective antagonists. A common interaction pattern was proposed for a series of structurally different MT(2) selective antagonists, which were positioned within the binding site by docking and simulated annealing. The proposed antagonist binding mode to the MT(2) receptor is characterized by the accommodation of the out-of-plane substituents in a hydrophobic pocket, which resulted as being fundamental for the explanation of the antagonist behavior and the MT(2) receptor selectivity. Moreover, to assess the ability of the MT(2) receptor model to reproduce the SARs of MT(2) antagonists, three new derivatives of the MT(2) selective antagonist N-[1-(4-chloro-benzyl)-4-methoxy-1H-indol-2-ylmethyl]-propionamide (7) were synthesized and tested for their receptor affinity and intrinsic activity. These compounds were docked into the MT(2) receptor model and were submitted to molecular dynamics studies, providing results in qualitative agreement with the experimental data. These results confirm the importance of the out-of-plane group in receptor binding and selectivity and provide a partial validation of the proposed G protein-coupled receptor model.

Knowledge Graph

Similar Paper

Analysis of Structure−Activity Relationships for MT<sub>2</sub> Selective Antagonists by Melatonin MT<sub>1</sub> and MT<sub>2</sub> Receptor Models
Journal of Medicinal Chemistry 2005.0
Three-Dimensional Quantitative Structure−Activity Relationship Studies on Selected MT<sub>1</sub>and MT<sub>2</sub>Melatonin Receptor Ligands:  Requirements for Subtype Selectivity and Intrinsic Activity Modulation
Journal of Medicinal Chemistry 2003.0
2-N-Acylaminoalkylindoles:  Design and Quantitative Structure−Activity Relationship Studies Leading to MT<sub>2</sub>-Selective Melatonin Antagonists
Journal of Medicinal Chemistry 2001.0
2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin Analogues: A Novel Class of MT<sub>2</sub>-Selective Melatonin Receptor Antagonists
Journal of Medicinal Chemistry 2009.0
Design and Synthesis ofN-(3,3-Diphenylpropenyl)alkanamides as a Novel Class of High-Affinity MT<sub>2</sub>-Selective Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2006.0
N-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2007.0
2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin – a novel MT2-selective melatonin receptor antagonist
MedChemComm 2011.0
Synthesis and Structure−Affinity−Activity Relationships of Novel Benzofuran Derivatives as MT<sub>2</sub> Melatonin Receptor Selective Ligands
Journal of Medicinal Chemistry 2002.0
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands
Bioorganic &amp; Medicinal Chemistry 2009.0
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity
Journal of Medicinal Chemistry 2004.0